High-income countries gained the most economic value from COVID-19 vaccines but low-income countries got the most per-person vaccinations relative to GDP.
|Articles|November 8, 2004
IDSA warns: New antibiotics needed ASAP
Once referred to as "miracle drugs" for their ability to eradicate infection and save countless lives, antibiotics are losing their battle against resistant organisms, and no fresh supply of novel drugs exists. Unless antibiotic research and development is reinvigorated soon, a public health crisis is imminent.
Advertisement
Advertisement
Related to this article
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 Vaccines Paid Off Up to $809 Per Dollar Spent in 2021
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Vaxcyte’s VAX-31 Pneumococcal Vaccine Meets All Phase 3 Primary Goals
4
The Outcome-Based Program That Could Reshape Pharmacists’ Roles
5